Clinical trial

Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs

NCT01068652

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-03-01

PhasePHASE4

Study timeline

Study start (unknown)2010-03-01Date precision: month

Registry last updated2017-01-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Diabetes Mellitus, Type 2unresolved

Interventions

insulin detemirDRUG · verified · RxNorm: insulin detemir

insulin aspartDRUG

biphasic insulin aspart 30DRUG

metforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01068652 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.